Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
1999 1
2000 1
2002 1
2003 3
2004 2
2005 3
2006 3
2007 6
2008 4
2009 2
2010 9
2011 12
2012 8
2013 20
2014 23
2015 28
2016 27
2017 36
2018 37
2019 36
2020 55
2021 68
2022 79
2023 107
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

535 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for rating xia
Search for Riting Xia instead (3 results)
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A. Cortese S, et al. Lancet Psychiatry. 2018 Sep;5(9):727-738. doi: 10.1016/S2215-0366(18)30269-4. Epub 2018 Aug 7. Lancet Psychiatry. 2018. PMID: 30097390 Free PMC article.
By contrast, for available comparisons based on teachers' ratings, only methylphenidate (SMD -0.82, 95% CI -1.16 to -0.48) and modafinil (-0.76, -1.15 to -0.37) were more efficacious than placebo. ...In head-to-head comparisons, only differences in efficacy (clinicians' …
By contrast, for available comparisons based on teachers' ratings, only methylphenidate (SMD -0.82, 95% CI -1.16 to -0.48) and modafi …
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
The primary outcome was the change from baseline in the score on the Clinical Dementia Rating scale-Sum of Boxes (CDR-SB; range, 0 to 18, with higher scores indicating greater cognitive impairment) at week 116. ...
The primary outcome was the change from baseline in the score on the Clinical Dementia Rating scale-Sum of Boxes (CDR-SB; range, 0 to …
Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies.
Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y, Cui Y, Shen X, Wu X. Xia L, et al. Cancer Med. 2020 Nov;9(21):7964-7978. doi: 10.1002/cam4.3428. Epub 2020 Sep 13. Cancer Med. 2020. PMID: 32924316 Free PMC article. Review.
CONCLUSIONS AND IMPLICATIONS: Sarcopenia significantly affected a wide range of adverse health-related outcomes, particularly in patients of tumor and elderly populations. Because evidences of most outcomes were rated as "low" and "very low," more prospective cohort studie …
CONCLUSIONS AND IMPLICATIONS: Sarcopenia significantly affected a wide range of adverse health-related outcomes, particularly in patients of …
Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery: A Randomized Clinical Trial.
Xu LL, Wang C, Deng CM, Dai SB, Zhou Q, Peng YB, Shou HY, Han YQ, Yu J, Liu CH, Xia F, Zhang SQ, Wang DX, Chen XZ. Xu LL, et al. JAMA Netw Open. 2023 Apr 3;6(4):e239321. doi: 10.1001/jamanetworkopen.2023.9321. JAMA Netw Open. 2023. PMID: 37083664 Free PMC article. Clinical Trial.
MAIN OUTCOMES AND MEASURES: The coprimary outcomes included scores on the numeric rating scale of pain (an 11-point scale, with 0 indicating no pain and 10 indicating the worst pain; a difference of 1.65 points was clinically meaningful) and Ramsay Sedation Scale (a 6-poin …
MAIN OUTCOMES AND MEASURES: The coprimary outcomes included scores on the numeric rating scale of pain (an 11-point scale, with 0 ind …
Influences of digital media use on children and adolescents with ADHD during COVID-19 pandemic.
Shuai L, He S, Zheng H, Wang Z, Qiu M, Xia W, Cao X, Lu L, Zhang J. Shuai L, et al. Global Health. 2021 Apr 19;17(1):48. doi: 10.1186/s12992-021-00699-z. Global Health. 2021. PMID: 33874977 Free PMC article.
Children scoring higher than predetermined cut-off point in self-rating questionnaires for problematic mobile phone use (SQPMPU) or Young's internet addiction test (IAT), were defined as ADHD with problematic digital media use (PDMU), otherwise were defined as ADHD without …
Children scoring higher than predetermined cut-off point in self-rating questionnaires for problematic mobile phone use (SQPMPU) or Y …
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.
Ashina M, Tepper SJ, Reuter U, Blumenfeld AM, Hutchinson S, Xia J, Miceli R, Severt L, Finnegan M, Trugman JM. Ashina M, et al. Headache. 2023 Jan;63(1):79-88. doi: 10.1111/head.14439. Epub 2023 Jan 18. Headache. 2023. PMID: 36651532 Free PMC article. Clinical Trial.
The primary objective was to evaluate the safety and tolerability of atogepant; safety assessments included treatment-emergent adverse events (TEAEs), clinical laboratory evaluations, vital signs, and Columbia-Suicide Severity Rating Scale scores. Efficacy assessments (ato …
The primary objective was to evaluate the safety and tolerability of atogepant; safety assessments included treatment-emergent adverse event …
Tai Chi for improving balance and reducing falls: An overview of 14 systematic reviews.
Zhong D, Xiao Q, Xiao X, Li Y, Ye J, Xia L, Zhang C, Li J, Zheng H, Jin R. Zhong D, et al. Ann Phys Rehabil Med. 2020 Nov;63(6):505-517. doi: 10.1016/j.rehab.2019.12.008. Epub 2020 Jan 22. Ann Phys Rehabil Med. 2020. PMID: 31981834 Free article.
Secondary outcomes included these outcomes in stroke, osteoarthritis and heart failure. RESULTS: A total of 14 relevant SRs were included: 13 were rated critically low quality and 1 was rated low quality by AMSTAR 2. ...With regard to Domain 2, assessing the identif …
Secondary outcomes included these outcomes in stroke, osteoarthritis and heart failure. RESULTS: A total of 14 relevant SRs were included: 1 …
Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years.
Zhou H, Xu X, Yan W, Zou X, Wu L, Luo X, Li T, Huang Y, Guan H, Chen X, Mao M, Xia K, Zhang L, Li E, Ge X, Zhang L, Li C, Zhang X, Zhou Y, Ding D, Shih A, Fombonne E, Zheng Y, Han J, Sun Z, Jiang YH, Wang Y; LATENT-NHC Study Team. Zhou H, et al. Neurosci Bull. 2020 Sep;36(9):961-971. doi: 10.1007/s12264-020-00530-6. Epub 2020 Jun 30. Neurosci Bull. 2020. PMID: 32607739 Free PMC article.
We targeted the population of 6 to 12-year-old children for this prevalence study by multistage convenient cluster sampling. The Modified Chinese Autism Spectrum Rating Scale was used for the screening process. Of the target population of 142,086 children, 88.5% (n = 125,8 …
We targeted the population of 6 to 12-year-old children for this prevalence study by multistage convenient cluster sampling. The Modified Ch …
Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiency.
Zhu C, Zhang Y, Wang T, Lin Y, Yu J, Xia Q, Zhu P, Zhu DM. Zhu C, et al. Brain Behav. 2020 Nov;10(11):e01760. doi: 10.1002/brb3.1760. Epub 2020 Sep 18. Brain Behav. 2020. PMID: 32945627 Free PMC article. Clinical Trial.
Psychological symptoms were evaluated with the Hamilton Depression Rating Scale-17 (HAMD-17), Revised Social Anhedonia Scale (RSAS), Revised Physical Anhedonia scale (RPAS), and Hamilton Anxiety Rating Scale-14 (HAMA-14). ...
Psychological symptoms were evaluated with the Hamilton Depression Rating Scale-17 (HAMD-17), Revised Social Anhedonia Scale (RSAS), …
Long-COVID-19 clinical and health outcomes: an umbrella review.
Li H, Xia J, Bennett D, Roque F, Bam RA, Tavares ABT, Gokhale M, Ida F, Rhee JJ, Soriano Gabarro M, Song Y. Li H, et al. Ther Adv Infect Dis. 2023 Sep 13;10:20499361231198335. doi: 10.1177/20499361231198335. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 37720384 Free PMC article. Review.
CONCLUSION: This study confirmed a high prevalence of several long COVID-19 outcomes according to the MedDRA categories and indicated that the majority of evidence was rated as moderate to low. REGISTRATION: The review was registered at PROSPERO (https://www.crd.york.ac.uk …
CONCLUSION: This study confirmed a high prevalence of several long COVID-19 outcomes according to the MedDRA categories and indicated that t …
535 results